Related references
Note: Only part of the references are listed.Progressive Multifocal Leukoencephalopathy: Why Gray and White Matter
Sarah Gheuens et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 8 (2013)
Co-occurrence of two cases of progressive multifocal leukoencephalopathy in a natalizumab infusion group
J. Havla et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
John Cunningham Virus Antibody and Viremia as Predictors of Progressive Multifocal Leukoencephalopathy in Human Immunodeficiency Virus-1-Infected Individuals
Raphael P. Viscidi et al.
CLINICAL INFECTIOUS DISEASES (2011)
Anti-JC Virus Antibodies: Implications for PML Risk Stratification
Leonid Gorelik et al.
ANNALS OF NEUROLOGY (2010)
Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis
Chen S. Tan et al.
LANCET NEUROLOGY (2010)
Transcriptional control region rearrangements associated with the evolution of JC polyomavirus
Yoshiaki Yogo et al.
VIROLOGY (2008)
A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy
RA Du Pasquier et al.
BRAIN (2004)
JC virus regulatory region tandem repeats in plasma and central nervous system isolates correlate with poor clinical outcome in patients with progressive multifocal leukoencephalopathy
LA Pfister et al.
JOURNAL OF VIROLOGY (2001)
Share Paper
